Utilizing PSA to understand and potentially predict the impact on a man’s survival is even more relevant than predicting the presence of prostate cancer and could significantly inform the decision whether to biopsy older men, especially healthy ones with longer life expectancies. The gene discussed is KLK3; the disease is Familial prostate cancer.